26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
The New Jersey Appellate Division recently affirmed a decision of the Civil Service Commission impos...
Read More >
Minimum wage bill heads to the Governor - On a vote of 23-6, the Senate voted on Thursday to concur...
Read More >
Many high-profile transactions impacted by the COVID-19 pandemic have fallen apart between signing a...
Read More >
In 1980, Congress enacted the Comprehensive Environmental Response, Compensation, and Liability Act ...
Read More >
Springsteen. Sinatra. Chuck Wepner (for at least one night in 1975 and then through the “Rocky” ...
Read More >
Following through with its promise to take enforcement actions against companies marketing cannabis-...
Read More >